[go: up one dir, main page]

MX2015001340A - Producto novedoso de leche fermentada y metodo para preparar el mismo. - Google Patents

Producto novedoso de leche fermentada y metodo para preparar el mismo.

Info

Publication number
MX2015001340A
MX2015001340A MX2015001340A MX2015001340A MX2015001340A MX 2015001340 A MX2015001340 A MX 2015001340A MX 2015001340 A MX2015001340 A MX 2015001340A MX 2015001340 A MX2015001340 A MX 2015001340A MX 2015001340 A MX2015001340 A MX 2015001340A
Authority
MX
Mexico
Prior art keywords
fermented milk
milk product
angiogenin
product
producing same
Prior art date
Application number
MX2015001340A
Other languages
English (en)
Inventor
Aiko Ohmachi
Hiroaki Matsuyama
Yoshikazu Morita
Yuko Ishida
Takayuki Nara
Ken Kato
Atsushi Serizawa
Hiroshi Ueno
Hiroshi Urazono
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Publication of MX2015001340A publication Critical patent/MX2015001340A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A23C9/1465—Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención se relaciona con un producto de leche fermentada que comprende angiogenina y/o angiogenina hidrolizada en una cantidad de 0.9 mg/100 g hasta 150 mg/100 g, y cistatina y/o cistatina hidrolizada en la proporción en masa para la angiogenina y/o la angiogenina hidrolizada de 0.006 hasta 1.7.
MX2015001340A 2012-07-31 2012-07-31 Producto novedoso de leche fermentada y metodo para preparar el mismo. MX2015001340A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2012/069395 WO2014020679A1 (ja) 2012-07-31 2012-07-31 発酵乳類及びその製造方法

Publications (1)

Publication Number Publication Date
MX2015001340A true MX2015001340A (es) 2015-09-04

Family

ID=50027411

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015001340A MX2015001340A (es) 2012-07-31 2012-07-31 Producto novedoso de leche fermentada y metodo para preparar el mismo.

Country Status (15)

Country Link
US (3) US20150230485A1 (es)
EP (1) EP2880981A4 (es)
JP (1) JP6124419B2 (es)
KR (2) KR20190095540A (es)
CN (1) CN104507320B (es)
AU (1) AU2012386762B2 (es)
BR (1) BR112015002047A2 (es)
CA (1) CA2879952C (es)
HK (1) HK1207252A1 (es)
MX (1) MX2015001340A (es)
MY (2) MY167580A (es)
PH (1) PH12015500051B1 (es)
SG (1) SG11201500454VA (es)
TW (1) TWI620505B (es)
WO (1) WO2014020679A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012386760B2 (en) * 2012-07-31 2016-05-05 Megmilk Snow Brand Co., Ltd. Beverage, and method for producing same
CN106526035A (zh) * 2015-12-17 2017-03-22 中国医科大学 可实现马血清白蛋白鉴定及绝对定量的试剂盒及测定方法
KR101867768B1 (ko) * 2016-08-12 2018-06-15 한국식품연구원 락토바실러스 아시도필루스를 포함하는 갱년기 예방 또는 치료용 조성물
DE102017222423A1 (de) 2017-12-11 2018-11-29 Thyssenkrupp Ag Formationsanlage und Formationsverfahren mit lokaler Rekuperation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2568151B2 (ja) * 1992-10-24 1996-12-25 雪印乳業株式会社 アンジオジェニンの単離方法
JPH06247871A (ja) * 1993-02-23 1994-09-06 Snow Brand Milk Prod Co Ltd 発育促進剤
JP3112637B2 (ja) 1994-09-30 2000-11-27 雪印乳業株式会社 骨強化剤
JPH08165249A (ja) * 1994-12-14 1996-06-25 Snow Brand Milk Prod Co Ltd 骨強化作用を有する組成物
JP2974604B2 (ja) * 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP3929088B2 (ja) 1996-06-20 2007-06-13 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
JP4592127B2 (ja) 1999-03-30 2010-12-01 雪印乳業株式会社 骨吸収抑制剤
AU784087B2 (en) * 2000-06-09 2006-02-02 Megmilk Snow Brand Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
JP2001346519A (ja) * 2000-06-09 2001-12-18 Snow Brand Milk Prod Co Ltd 乳塩基性シスタチン高含有画分及びその分解物の製造方法
JP4647750B2 (ja) * 2000-06-20 2011-03-09 雪印乳業株式会社 乳塩基性シスタチン高含有画分及びその分解物の製造法
US6649590B2 (en) * 2000-06-09 2003-11-18 Snow Brand Milk Products Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
JP2004238320A (ja) * 2003-02-05 2004-08-26 Snow Brand Milk Prod Co Ltd 骨吸収抑制剤
JP4536341B2 (ja) * 2003-08-15 2010-09-01 雪印乳業株式会社 骨形成促進剤
US20060289354A1 (en) * 2005-06-15 2006-12-28 Buckman Laboratories International, Inc. Method and composition to control the growth of microorganisms in aqueous systems and on substrates
NZ547859A (en) * 2006-06-09 2009-05-31 Dec Int Nz Ltd Treatment method and composition for mastitis
NZ577195A (en) * 2006-11-10 2011-12-22 Murray Goulburn Coop Co Ltd Process for the preparation of angiogenin using a cation exchange resin
JP4913587B2 (ja) 2006-12-28 2012-04-11 雪印メグミルク株式会社 ペプチドおよびタンパク質定量法
WO2009137879A1 (en) * 2008-05-14 2009-11-19 Agriculture Victoria Services Pty Ltd Orally administrable dosage forms comprising angiogenin and uses thereof
CN102088995B (zh) * 2008-05-14 2016-01-20 维多利亚农业服务控股公司 血管生成素和血管生成素激动剂用于治疗疾病和障碍的用途
WO2010058679A1 (ja) * 2008-11-18 2010-05-27 国立大学法人 九州大学 骨折修復促進剤

Also Published As

Publication number Publication date
CA2879952A1 (en) 2014-02-06
EP2880981A4 (en) 2016-01-13
CA2879952C (en) 2019-09-03
TW201408213A (zh) 2014-03-01
AU2012386762A1 (en) 2015-03-05
EP2880981A1 (en) 2015-06-10
PH12015500051A1 (en) 2015-03-02
SG11201500454VA (en) 2015-04-29
HK1207252A1 (en) 2016-01-29
CN104507320A (zh) 2015-04-08
KR20190095540A (ko) 2019-08-14
PH12015500051B1 (en) 2015-03-02
TWI620505B (zh) 2018-04-11
BR112015002047A2 (pt) 2017-07-04
JP6124419B2 (ja) 2017-05-10
WO2014020679A1 (ja) 2014-02-06
CN104507320B (zh) 2018-05-01
US20190313658A1 (en) 2019-10-17
MY167580A (en) 2018-09-20
NZ704915A (en) 2016-01-29
AU2012386762B2 (en) 2016-05-05
KR20150036683A (ko) 2015-04-07
US20150230485A1 (en) 2015-08-20
US20170332652A1 (en) 2017-11-23
JPWO2014020679A1 (ja) 2016-07-11
MY167428A (en) 2018-08-28

Similar Documents

Publication Publication Date Title
WO2015189345A3 (en) Compositions and methods for the diagnosis and treatment of bone fractures and disorders
HK1221171A1 (zh) 用於刺激骨生长的组合物
EP2999747A4 (en) Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
NZ708928A (en) Mannose derivatives for treating bacterial infections
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
CN107405369A8 (zh) 包含细菌的组合物及将其用于治疗和/或预防胃肠道疾病、代谢疾病和/或其它疾病的方法
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
ZA201303529B (en) Implantable device for preventive or curative treatment of fractures of the femur, associated ancillary device
PH12015500051A1 (en) Novel fermented milk product and method for producing the same
PH12015500049A1 (en) Novel portein material
EP3603657A4 (en) COMPOSITION CONTAINING AMOMUM VILLOSUM EXTRACT FOR THE PREVENTION, REDUCTION OR TREATMENT OF OBESITY
MX2015001344A (es) Producto novedoso de leche fermentada y metodo para preparar el mismo.
MX2013002118A (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
PH12015500053A1 (en) Novel cheese and method for producing the same
PH12015500052A1 (en) Novel powdered milk product and method for producing the same
NZ610547A (en) Novel monensin derivatives for the treatment and prevention of protozoal infections
MY167429A (en) Novel cheese and method for producing the same
WO2016182812A8 (en) Activation of neuronal store-operated calcium entry pathway for the treatment of alzheimer's disease
PH12015500050A1 (en) Beverage, and method of producing the same
MY181546A (en) Beverage, and method of producing the same
PH12015500048B1 (en) Novel protein material
MY167427A (en) Beverage, and method of producing the same
GB2530226A (en) Chewable tablet